Search research articles
Contact Us
Filters
Showing results (91-100 of 139) with videos related to
Page
of 14
Sort By:
Infectious Agents and Cancer
|
April 18, 2021
Immunophenotypic characterization of TCR γδ T cells and MAIT cells in HIV-infected individuals developing Hodgkin's lymphoma
Christina K S Muller, Julian Spagnuolo, Annette Audigé, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 12, 2020
The Role of Human Immunodeficiency Virus (HIV) Asymptomatic Status When Starting Antiretroviral Therapy on Adherence and Treatment Outcomes and Implications for Test and Treat: The Swiss HIV Cohort Study
Tracy R Glass, Huldrych F Günthard, Alexandra Calmy, et al.
Plos Pathogens
|
March 24, 2015
Persistence of transmitted HIV-1 drug resistance mutations associated with fitness costs and viral genetic backgrounds
Wan-Lin Yang, Roger D Kouyos, Jürg Böni, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
May 18, 2018
HIV-1 Drug Resistance Among Ugandan Adults Attending an Urban Out-Patient Clinic
Amrei von Braun, Christine Sekaggya-Wiltshire, Nadine Bachmann, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 15, 2011
Characterization of human immunodeficiency virus type 1 (HIV-1) diversity and tropism in 145 patients with primary HIV-1 infection
Philip Rieder, Beda Joos, Alexandra U Scherrer, et al.
Plos One
|
November 29, 2012
Long-lasting protection of activity of nucleoside reverse transcriptase inhibitors and protease inhibitors (PIs) by boosted PI containing regimens
Alexandra U Scherrer, Jürg Böni, Sabine Yerly, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 23, 2020
Predictors of Virological Failure and Time to Viral Suppression of First-Line Integrase Inhibitor-Based Antiretroviral Treatment
Ashima Pyngottu, Alexandra U Scherrer, Roger Kouyos, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 8, 2019
Emergence of Drug Resistance in the Swiss HIV Cohort Study Under Potent Antiretroviral Therapy Is Observed in Socially Disadvantaged Patients
Irene A Abela, Alexandra U Scherrer, Jürg Böni, et al.
The Journal of Infectious Diseases
|
May 19, 2016
Dually Active HIV/HBV Antiretrovirals as Protection Against Incident Hepatitis B Infections: Potential for Prophylaxis
Mohaned Shilaih, Alex Marzel, Alexandra U Scherrer, et al.
Plos One
|
October 23, 2010
Profound depletion of HIV-1 transcription in patients initiating antiretroviral therapy during acute infection
Adrian Schmid, Sara Gianella, Viktor von Wyl, et al.
Page
of 14
Search research articles
Search
Showing results (91-100 of 139) with videos related to
Sort By:
Page
of 14
Infectious Agents and Cancer
|
April 18, 2021
Immunophenotypic characterization of TCR γδ T cells and MAIT cells in HIV-infected individuals developing Hodgkin's lymphoma
Christina K S Muller, Julian Spagnuolo, Annette Audigé, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 12, 2020
The Role of Human Immunodeficiency Virus (HIV) Asymptomatic Status When Starting Antiretroviral Therapy on Adherence and Treatment Outcomes and Implications for Test and Treat: The Swiss HIV Cohort Study
Tracy R Glass, Huldrych F Günthard, Alexandra Calmy, et al.
Plos Pathogens
|
March 24, 2015
Persistence of transmitted HIV-1 drug resistance mutations associated with fitness costs and viral genetic backgrounds
Wan-Lin Yang, Roger D Kouyos, Jürg Böni, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
May 18, 2018
HIV-1 Drug Resistance Among Ugandan Adults Attending an Urban Out-Patient Clinic
Amrei von Braun, Christine Sekaggya-Wiltshire, Nadine Bachmann, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 15, 2011
Characterization of human immunodeficiency virus type 1 (HIV-1) diversity and tropism in 145 patients with primary HIV-1 infection
Philip Rieder, Beda Joos, Alexandra U Scherrer, et al.
Plos One
|
November 29, 2012
Long-lasting protection of activity of nucleoside reverse transcriptase inhibitors and protease inhibitors (PIs) by boosted PI containing regimens
Alexandra U Scherrer, Jürg Böni, Sabine Yerly, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 23, 2020
Predictors of Virological Failure and Time to Viral Suppression of First-Line Integrase Inhibitor-Based Antiretroviral Treatment
Ashima Pyngottu, Alexandra U Scherrer, Roger Kouyos, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 8, 2019
Emergence of Drug Resistance in the Swiss HIV Cohort Study Under Potent Antiretroviral Therapy Is Observed in Socially Disadvantaged Patients
Irene A Abela, Alexandra U Scherrer, Jürg Böni, et al.
The Journal of Infectious Diseases
|
May 19, 2016
Dually Active HIV/HBV Antiretrovirals as Protection Against Incident Hepatitis B Infections: Potential for Prophylaxis
Mohaned Shilaih, Alex Marzel, Alexandra U Scherrer, et al.
Plos One
|
October 23, 2010
Profound depletion of HIV-1 transcription in patients initiating antiretroviral therapy during acute infection
Adrian Schmid, Sara Gianella, Viktor von Wyl, et al.
Page
of 14